{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:04:16Z","timestamp":1771268656181,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":136,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001478.pub3","type":"reference-entry","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T09:56:47Z","timestamp":1208771807000},"source":"Crossref","is-referenced-by-count":3,"title":["Acellular vaccines for preventing whooping cough in children"],"prefix":"10.1002","author":[{"given":"Linjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvio OM","family":"Prietsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02724936.1996.11747802","article-title":"Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana","volume":"16","author":"Afari","year":"1996","journal-title":"Annals of Tropical Paediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB2|cit2","first-page":"955","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events [published erratum appears in Lancet 1988 May 28;1(8596):1238]","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD001478.pub3-BIB4|cit4","first-page":"1994","article-title":"Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial","volume":"85","author":"Kallings","year":"1988","journal-title":"Lakartidningen"},{"key":"10.1002\/14651858.CD001478.pub3-BIB5|cit5","first-page":"143","article-title":"Invasive bacterial infections during an efficacy trial of acellular pertussis vaccines - implications for future surveillance in pertussis vaccine programmes","volume":"13","author":"Olin","year":"1988","journal-title":"The Tokai Journal of Experimental and Clinical Medicine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB6|cit6","unstructured":"Olin P Storsaeter J Linder T Winter C S\u00f6nstenby C A clinical trial of acellular pertussis vaccines in Sweden Technical Report 1988 1988215677"},{"key":"10.1002\/14651858.CD001478.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0264-410X(90)90246-I","article-title":"Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial","volume":"8","author":"Storsaeter","year":"1990","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00006454-198809000-00008","article-title":"Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden","volume":"7","author":"Storsaeter","year":"1988","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001478.pub3-BIB9|cit9","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB10|cit10","first-page":"99","article-title":"Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB11|cit11","unstructured":"Olin P Gustafsson L Rasmussen H Hallander H Heijbel H Gottfarb P Efficacy trial of acellular pertussis vaccines. Technical report trial II with preplanned analysis of efficacy, immunogenicity and safety Swedish Institute for Infectious Disease Control 1997"},{"key":"10.1002\/14651858.CD001478.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/157.4.731","article-title":"Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants","volume":"157","author":"Anderson","year":"1988","journal-title":"The Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub3-BIB14|cit14","first-page":"556","article-title":"Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children [published errata appear in Am J Dis Child 1992 Jul;1 46(7):802 and 1992 Sep;146(9):1084]","volume":"146","author":"Bernstein","year":"1992","journal-title":"American Journal of Diseases of Children"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1542\/peds.93.4.656","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants","volume":"93","author":"Bernstein","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00006454-199701000-00012","article-title":"Safety and immunogenicity of Chiron\/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers","volume":"16","author":"Black","year":"1997","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1542\/peds.82.3.293","article-title":"Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial","volume":"82","author":"Blennow","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB18|cit18","first-page":"185","article-title":"Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6","volume":"65","author":"Blennow","year":"1986","journal-title":"Developments in Biological Standardization"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01962341","article-title":"Protective effect of acellular pertussis vaccines","volume":"7","author":"Blennow","year":"1988","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001478.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(05)82442-4","article-title":"Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody","volume":"117","author":"Blumberg","year":"1990","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB21|cit21","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups","volume":"73","author":"Cherry","year":"1991","journal-title":"Developments in Biological Standardization"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3476(05)80727-9","article-title":"Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group","volume":"119","author":"Blumberg","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001478.pub3-BIB24|cit23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/infdis\/174.Supplement_3.S270","article-title":"The multicenter acellular pertussis trial: an overview","volume":"174","author":"Decker","year":"1996","journal-title":"The Journal of Infectious Diseases"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub3-BIB23|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"issue":"3 pt 2","key":"10.1002\/14651858.CD001478.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1542\/peds.96.3.592","article-title":"Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations","volume":"96","author":"Deloria","year":"1995","journal-title":"Pediatrics"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpedi.1986.02140230037024","article-title":"Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components","volume":"140","author":"Edwards","year":"1986","journal-title":"American Journal of Diseases of Children"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpedi.1986.02140230037024","article-title":"Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components","volume":"140","author":"Edwards","year":"1986","journal-title":"American Journal of Diseases of Children"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"The Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"The Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"The Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/166.6.1436","article-title":"Controlled study of a new five-component acellular pertussis vaccine in adults and young children","volume":"166","author":"Englund","year":"1992","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3476(05)80328-2","article-title":"Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children [published erratum appears in J Pediatr 1993 Nov;123(5):842]","volume":"121","author":"Feldman","year":"1992","journal-title":"The Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"269-75, 284","DOI":"10.1097\/00007611-199303000-00002","article-title":"Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids","volume":"86","author":"Feldman","year":"1993","journal-title":"The Southern Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD001478.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00006454-199207000-00005","article-title":"Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children","volume":"11","author":"Glode","year":"1992","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001478.pub3-BIB38|cit38","first-page":"77","article-title":"Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials","volume":"89","author":"Ciofi degli Atti","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB40|cit39","first-page":"55","article-title":"Italian trial on acellular pertussis vaccines","volume":"89","author":"Greco","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB39|cit40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group","volume":"334","author":"Greco","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB41|cit41","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB42|cit42","first-page":"105","article-title":"Common side effects in the Italian and Stockholm I trials","volume":"89","author":"Tozzi","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB43|cit43","first-page":"77","article-title":"Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials","volume":"89","author":"Ciofi degli Atti","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB44|cit44","unstructured":"Gustaffson L Hallander H Olin P Reizenstein E Storsaeter J Efficacy trial of acellular pertussis vaccines. Technical report Trial I with results of preplanned analysis of safety, efficacy and immunogenicity Swedish Institute for Infectious Disease Control 1995"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [see comments]","volume":"334","author":"Gustafsson","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB46|cit46","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB47|cit47","first-page":"52","article-title":"Efficacy trial of acellular pertussis vaccines; trial I","volume":"89","author":"Olin","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB48|cit48","first-page":"105","article-title":"Common side effects in the Italian and Stockholm I trials","volume":"89","author":"Tozzi","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archpedi.1994.02170110106025","article-title":"Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities","volume":"148","author":"Halperin","year":"1994","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archpedi.1994.02170110106025","article-title":"Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities","volume":"148","author":"Halperin","year":"1994","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199509000-00012","article-title":"Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole-cell or acellular pertussis vaccine at two, four and six months of age","volume":"14","author":"Halperin","year":"1995","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0264-410X(95)00250-5","article-title":"Adverse reactions and antibody response to four doses of acellular or whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life","volume":"14","author":"Halperin","year":"1996","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00006454-199909000-00006","article-title":"Comparison of a fifth dose of a five-component acellular or a whole-cell pertussis vaccine in children four to six years of age","volume":"18","author":"Halperin","year":"1999","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"19-20","key":"10.1002\/14651858.CD001478.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/S0264-410X(03)00173-7","article-title":"Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine","volume":"21","author":"Halperin","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(94)90014-0","article-title":"Comparative study of Lederle\/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany","volume":"12","author":"Heininger","year":"1994","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children","volume":"152","author":"Kanra","year":"1993","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children","volume":"152","author":"Kanra","year":"1993","journal-title":"European Jounal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0264-410X(03)00496-1","article-title":"Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine","volume":"21","author":"Kosuwon","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub3-BIB59|cit59","first-page":"872","article-title":"A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children","volume":"140","author":"Lewis","year":"1986","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB60|cit60","first-page":"290","article-title":"Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children [published erratum appears in Am J Dis Child 1993 Jun;1 47(6):626]","volume":"147","author":"Marcinak","year":"1993","journal-title":"American Journal of Diseases of Children"},{"issue":"8733","key":"10.1002\/14651858.CD001478.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0140-6736(91)90735-8","article-title":"Phase II trial of whole-cell pertussis vaccine versus an acellular vaccine containing agglutinogens","volume":"337","author":"Miller","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub3-BIB62|cit62","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups","volume":"73","author":"Cherry","year":"1991","journal-title":"Developments in Biological Standardization"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD001478.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1203\/00006450-199004000-00007","article-title":"Metabolic and hematologic effects and immune complex formation related to pertussis immunization","volume":"27","author":"Mink","year":"1990","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archpedi.1990.02150250047029","article-title":"Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children","volume":"144","author":"Morgan","year":"1990","journal-title":"American Journal of Diseases of Children"},{"issue":"5 pt1","key":"10.1002\/14651858.CD001478.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.89.5.882","article-title":"Acellular pertussis vaccination of 2-month-old infants in the United States","volume":"89","author":"Pichichero","year":"1992","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB66|cit66","first-page":"295","article-title":"Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants","volume":"1 47","author":"Pichichero","year":"1993","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-199403000-00005","article-title":"Comparison of a three-component acellular pertussis vaccine with whole-cell pertussis vaccine in two-month-old children","volume":"13","author":"Pichichero","year":"1994","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00365549609049068","article-title":"Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole-cell pertussis vaccine","volume":"28","author":"Pichichero","year":"1996","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.105.1.e11","article-title":"Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children","volume":"105","author":"Pichichero","year":"2000","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(05)83181-6","article-title":"Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine","volume":"124","author":"Podda","year":"1994","journal-title":"The Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB72|cit72","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB73|cit73","first-page":"113","article-title":"Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group","volume":"89","author":"Schmitt-Grohe","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB75|cit74","first-page":"58","article-title":"A comparative efficacy trial in Germany in which infants received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine","volume":"89","author":"Stehr","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB74|cit75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB76|cit76","first-page":"83","article-title":"Uberall MA, Stehr K, Cherry JD, et al Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group","volume":"89","author":"Uberall","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub3-BIB77|cit77","first-page":"854","article-title":"Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines","volume":"147","author":"Rothstein","year":"1993","journal-title":"American Journal of Diseases of Children"},{"issue":"12","key":"10.1002\/14651858.CD001478.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF01690510","article-title":"Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants","volume":"15","author":"Simondon","year":"1996","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1002\/14651858.CD001478.pub3-BIB79|cit79","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB80|cit80","first-page":"91","article-title":"The Senegal pertussis trial: safety and surveillance of adverse reactions","volume":"89","author":"Preziosi","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB82|cit81","first-page":"63","article-title":"Senegal pertussis trial","volume":"89","author":"Simondon","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"15","key":"10.1002\/14651858.CD001478.pub3-BIB81|cit82","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB83|cit83","first-page":"155","article-title":"An observation on immunization reaction and serological effect of adsorbed purified pertussis vaccine","volume":"14","author":"Tian","year":"1993","journal-title":"Chung Hua Liu Hsing Ping Hsueh Tsa Chih"},{"key":"10.1002\/14651858.CD001478.pub3-BIB84|cit84","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB85|cit85","first-page":"109","article-title":"Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial","volume":"89","author":"Taranger","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB87|cit86","first-page":"49","article-title":"The Gothenburg pertussis vaccine study","volume":"89","author":"Trollfors","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB86|cit87","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0264-410X(94)90196-1","article-title":"Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccine","volume":"12","author":"Vanura","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpedi.1994.02170050061011","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates","volume":"148","author":"Annunziato","year":"1994","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00006454-199302000-00005","article-title":"Comparison of acellular pertussis vaccine with whole-cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age","volume":"12","author":"Bernstein","year":"1993","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"17","key":"10.1002\/14651858.CD001478.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/0264-410X(95)00137-P","article-title":"Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States","volume":"13","author":"Bernstein","year":"1995","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/02724936.1994.11747699","article-title":"A randomized controlled trial of two acellular pertussis-diphtheria-tetanus vaccine in primary immunization in Ghana: antibody responses and adverse reactions","volume":"14","author":"Hori","year":"1994","journal-title":"Annals of Tropical Paediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02724936.1995.11747762","article-title":"Pertussis immunization with acellular vaccines in Ghanaian children","volume":"15","author":"Hori","year":"1995","journal-title":"Annals of Tropical Paediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB94|cit94","first-page":"275","article-title":"Two trials of an acellular DTP vaccine in comparison with a whole-cell DTP vaccine in infants: evaluation of two PT doses and two vaccination schedules","volume":"73","author":"Just","year":"1991","journal-title":"Developments in Biological Standardization"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0264-410X(96)00112-0","article-title":"Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance","volume":"15","author":"Miller","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1542\/peds.71.2.200","article-title":"Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine","volume":"71","author":"Murphy","year":"1983","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006454-198704000-00004","article-title":"Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis versus. a whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children","volume":"6","author":"Pichichero","year":"1987","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB98|cit98","first-page":"863","article-title":"Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants","volume":"34","author":"Shek","year":"2003","journal-title":"The Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"10.1002\/14651858.CD001478.pub3-BIB99|cit99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00431-007-0548-2","article-title":"What is new in pertussis? \u00a0","volume":"167","author":"Bamberger","year":"2008","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(05)62352-5","article-title":"Does blinding of readers affect the results of meta-analyses?","volume":"350","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.inf.0000247055.81541.04","article-title":"The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada","volume":"26","author":"Bettinger","year":"2007","journal-title":"Pediatric Infectious Disease"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1542\/peds.2004-2759","article-title":"Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001","volume":"116","author":"Bisgard","year":"2005","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"American Journal of Diseases of Children"},{"issue":"10","key":"10.1002\/14651858.CD001478.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2165\/00003495-200565100-00005","article-title":"Acellular Pertussis Vaccine Safety and Efficacy in Children, Adolescents and Adults. Review Article","volume":"65","author":"Casey","year":"2005","journal-title":"Drug"},{"key":"10.1002\/14651858.CD001478.pub3-BIB105|cit105","unstructured":"CDC Recommendations and Guidelines: 2009 Child & Adolescent Immunization Schedules http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/child-schedule.htm 2009"},{"key":"10.1002\/14651858.CD001478.pub3-BIB106|cit106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimionian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001478.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub3-BIB108|cit108","first-page":"123","article-title":"Implications of different study designs for the evaluation of acellular pertussis vaccines","volume":"89","author":"Fine","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB109|cit109","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1503\/cmaj.050379","article-title":"Changing epidemiology and emerging risk groups for pertussis","volume":"174","author":"Galanis","year":"2006","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD001478.pub3-BIB110|cit110","first-page":"379","article-title":"Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease?","volume":"89","author":"Granoff","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/sim.4780090307","article-title":"Bias in the one-step method for pooling study results","volume":"9","author":"Greenland","year":"1990","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"b1772","DOI":"10.1136\/bmj.b1772","article-title":"Practice: Easily missed? Whooping cough","volume":"338","author":"Harnden","year":"2009","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub3-BIB113|cit113","first-page":"844","article-title":"A clinical trial of a monocomponent pertussis toxoid vaccine","volume":"141","author":"Hedenskog","year":"1987","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD001478.pub3-BIB114|cit114","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]","volume-title":"The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Higgins","year":"2008"},{"issue":"13","key":"10.1002\/14651858.CD001478.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.vaccine.2005.12.009","article-title":"Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review","volume":"24","author":"Jacquet","year":"2006","journal-title":"Vaccine"},{"issue":"17-8","key":"10.1002\/14651858.CD001478.pub3-BIB116|cit116","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub3-BIB117|cit117","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1442-200x.2004.01970.x","article-title":"Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization","volume":"46","author":"Kuno-Sakai","year":"2004","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD001478.pub3-BIB118|cit118","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch6","article-title":"Chapter 6: Searching for studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Lefebvre","year":"2008"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub3-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006454-199711000-00007","article-title":"Efficacy of a two-component acellular pertussis vaccine in infants","volume":"16","author":"Liese","year":"1997","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bjs.6302","article-title":"Assessment of publication bias for the surgeon scientist","volume":"95","author":"Mahid","year":"2008","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD001478.pub3-BIB121|cit121","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB122|cit122","first-page":"1","article-title":"Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Murphy","year":"2008","journal-title":"MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries \/ Centers for Disease Control"},{"key":"10.1002\/14651858.CD001478.pub3-BIB123|cit123","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsa0806477","article-title":"Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases","volume":"360","author":"Omer","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001478.pub3-BIB124|cit124","volume-title":"Meta-analysis, decision analysis and cost-effectiveness analysis: Methods for quantitative synthesis in medicine","author":"Petitti","year":"1989"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD001478.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.inf.0000166157.21561.78","article-title":"Acellular pertussis vaccines for adolescents","volume":"24","author":"Pichichero","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"7","key":"10.1002\/14651858.CD001478.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0009922806289593","article-title":"Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP\/DTwP schedules","volume":"45","author":"Pichichero","year":"2006","journal-title":"Clinical Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB127|cit127","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2307\/2531052","article-title":"Estimators of the Mantel-Haenszel variance consistent with both sparse and large-strata limiting models","volume":"42","author":"Robins","year":"1986","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD001478.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.vaccine.2008.09.042","article-title":"Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review","volume":"26","author":"Rodr\u00edguez-Cobo","year":"2008","journal-title":"Vaccine"},{"issue":"8369","key":"10.1002\/14651858.CD001478.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.275.1.37","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001478.pub3-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1378\/chest.130.5.1547","article-title":"Whooping Cough","volume":"130","author":"Singh","year":"2006","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001478.pub3-BIB132|cit132","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00006454-199702000-00003","article-title":"Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants","volume":"16","author":"Taranger","year":"1997","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB133|cit133","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14760584.4.2.173","article-title":"Acellular pertussis vaccines in Japan: past, present and future","volume":"4","author":"Watanabe","year":"2005","journal-title":"Expert Review of Vaccines"},{"key":"10.1002\/14651858.CD001478.pub3-BIB134|cit134","unstructured":"WHO WHO meeting on case definitions of pertussis MIN\/EPI\/PERT\/91 1991 4 5"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub3-BIB135|cit135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001478","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Tinnion","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub3-BIB136|cit136","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Tinnion","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001478.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T21:25:28Z","timestamp":1684358728000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001478.pub3"}},"subtitle":[],"editor":[{"given":"Linjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":136,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001478.pub3","relation":{},"subject":[],"published":{"date-parts":[[2008,4,23]]}}}